Roche provides update on Phase III MARIANNE study in people with previously untreated advanced HER2-positive breast cancer
19 December 2014 | By Roche
Roche announced top-line results of the Phase III MARIANNE study...
List view / Grid view
News
Pfizer reports top-line results from a Phase 3 study evaluating pregabalin controlled-release formulation as a treatment for patients with postherpetic neuralgia
19 December 2014 | By Pfizer
Pfizer Inc. (NYSE:PFE) announced today top-line results from a double-blind Phase 3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (pain after shingles or PHN).
Lilly’s CYRAMZA(R) (ramucirumab) receives third FDA approval
17 December 2014 | By Eli Lilly and Company
Eli Lilly and Company has received its third U.S. Food and Drug Administration (FDA) approval for CYRAMZA(R) (ramucirumab)...
Top 30 pharma companies spent $112 billion on research and development in 2013, says GlobalData
17 December 2014 | By GlobalData
The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development (R&D) in 2013, an increase of $723 million over the previous year, according to research and consulting firm GlobalData...
Selvita has raised PLN 27.3 MM on its way to the main market of the Warsaw Stock Exchange
17 December 2014 | By Selvita
Selvita, Poland-based integrated drug discovery partner for the pharmaceutical and biotechnology industry, has successfully completed its Initial Public Offering...
First trial of a novel oral anticoagulant starts in prevention of recurrent stroke due to a blood clot of undetermined source
16 December 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announces that the first patient has been enrolled in the RE-SPECT ESUS™ phase III study to investigate the efficacy and safety of dabigatran etexilate for the prevention of recurrent Embolic Stroke of Undetermined Source, also called ESUS...
Cambridge structural database reaches 750,000 entry milestone
16 December 2014 | By The Cambridge Crystallographic Data Centre
Essential resource to scientists around the world reaches historic record...
Abbott commences tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022
16 December 2014 | By Abbott
Abbott announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Notes Offer"), in which it is offering to purchase for cash any and all of the outstanding $300 million aggregate principal amount of 5.125% Senior Notes due…
Line dancing bacteria win the 2014 Dolomite and Lab on a Chip Video Competition
16 December 2014 | By kdm communications
The inaugural MicroTAS Video Competition, run by microfluidics specialist Dolomite and Lab on a Chip, and supported by the Chemical and Biological Microsystems Society, saw first prize awarded to an enterprising – and highly creative – entry submitted by Tijmen Hageman from the Korean Institute of Science and Technology (KIST)…
Orange and USAID join forces to boost mHealth innovations across Africa
15 December 2014 | By Orange
The U.S. Agency for International Development and global telecommunications operator Orange announced a new alliance to develop innovations in mobile health (mHealth) at the Global mHealth Forum in Washington, DC...
UK patients with moderately to severely active ulcerative colitis gain access to a range of biologic therapies on the NHS
15 December 2014 | By MSD
NICE says ‘yes’ to REMICADE® (infliximab), HUMIRA® (adalimumab) and SIMPONI® (golimumab) for adult patients with moderately to severely active ulcerative colitis...
Abbott completes acquisition of Veropharm
15 December 2014 | By Abbott
Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer...
Biotech-Cluster Rhine-Neckar (BioRN) leads InnoLife consortium to success in the competition Healthy Living and Active Ageing of the European Institute for Innovation and Technology (EIT)
15 December 2014 | By BioRN
Future role as German coordination centre for the largest European cooperation project in the health sector to date...
Ethiopia will receive 13 million praziquantel tablets in 2015
12 December 2014 | By Merck KGaA
Merck supports the World Health Organization (WHO) to fight the parasitic worm disease schistosomiasis in Africa...
Changes in Roche Board of Directors and enlarged Corporate Executive Committee
12 December 2014 | By Roche
At its December meeting, the Board of Directors (BoD) of Roche Holding recommended first proposals for approval by the AGM, scheduled for 3 March 2015...
